Evidence map›Paper›PMID 42437928›Full record

ArticleBMC veterinary research2026

Cross-sectional study of prevalence and economic importance of bovine fasciolosis at Kombolcha Elfora Abattoir, Amhara Region, Northern Ethiopia.

Degaga Guder Gemeda, Temesgen Takele Tafese

Abstract read
In one paragraph

Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Degaga Guder GemedaCollege of Veterinary Medicine, Haramaya University, Oromia, P.O.Box 138, Dire Dawa, Ethiopia. degagaguder2006@gmail.com.ORCID http://orcid.org/0009-0007-3001-8788
Temesgen Takele TafeseCollege of Veterinary Medicine, Haramaya University, Oromia, P.O.Box 138, Dire Dawa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study was conducted from October 2024 to June 2025 at the Kombolcha ELFORA abattoir and Processing Plant to assess the prevalence and economic impact of bovine Fasciolosis in cattle sourced from three agroecological zones in northern Ethiopia. From the 382 examined bovine samples, 184 faecal samples (48.17%) and 195 livers (51.05%) tested positive for Fasciolosis. Infection rates were highest in cattle with poor body condition (51.55% in faecal samples and 54.64% in livers), followed by medium (47.62% and 50%) and good body condition groups (20% and 25%, respectively), with significant differences observed between groups (p < 0.05). Breed and body condition were significantly associated with liver infection (p = 0.031 and p = 0.039, respectively). Species distribution varied by agroecology: among the 195 positive cattle, 83.56% and 16.44% of F. hepatica were from Dega and Weynadega, respectively; 94% and 6% of F. gigantica were from Kola and Weynadega; and all mixed infections (100%) occurred in Weynadega, showing significantly associated (P < 0.05) Fasciola species prevalence with agroecological variations. The direct and indirect financial losses due to bovine Fasciolosis at the Kombolcha ELFORA abattoir were estimated at approximately 7,218,521.05 Ethiopian birr per quarter. The study concluded that Fasciolosis is highly prevalent in cattle and imposes significant economic burdens, emphasising the necessity of targeted interventions by stakeholders and government authorities to support the beef industry in the region and across Ethiopia.

Indexed as

Cattle DiseasesFascioliasisAbattoirsAnimalsCattleCross-Sectional StudiesEthiopiaFasciolaFecesLiverPrevalenceAgroecologyFasciola giganticaFasciola hepaticaFinancial lossPrevalence

Identifiers

PMID42437928
PMCPMC13647729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.